Cargando…
Peri‐implantation urinary hormone monitoring distinguishes between types of first‐trimester spontaneous pregnancy loss
BACKGROUND: Lutenising hormone (LH) and human chorionic gonadotropin (hCG) hormone are useful biochemical markers to indicate ovulation and embryonic implantation, respectively. We explored “point‐of‐care” LH and hCG testing using a digital home‐testing device in a cohort trying to conceive. OBJECTI...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496486/ https://www.ncbi.nlm.nih.gov/pubmed/32056241 http://dx.doi.org/10.1111/ppe.12613 |
_version_ | 1783583107940614144 |
---|---|
author | Foo, Lin Johnson, Sarah Marriott, Lorrae Bourne, Tom Bennett, Phillip Lees, Christoph |
author_facet | Foo, Lin Johnson, Sarah Marriott, Lorrae Bourne, Tom Bennett, Phillip Lees, Christoph |
author_sort | Foo, Lin |
collection | PubMed |
description | BACKGROUND: Lutenising hormone (LH) and human chorionic gonadotropin (hCG) hormone are useful biochemical markers to indicate ovulation and embryonic implantation, respectively. We explored “point‐of‐care” LH and hCG testing using a digital home‐testing device in a cohort trying to conceive. OBJECTIVE: To determine conception and spontaneous pregnancy loss rates, and to assess whether trends in LH‐hCG interval which are known to be associated with pregnancy viability could be identified with point‐of‐care testing. METHODS: We recruited healthy women aged 18‐44 planning a pregnancy. Participants used a home monitor to track LH and hCG levels for 12 menstrual cycles or until pregnancy was conceived. Pregnancy outcomes (viable, clinical miscarriage, or biochemical pregnancy loss) were recorded. Monitor data were analysed by a statistician blinded to pregnancy outcome. RESULTS: From 387 recruits, there were 290 pregnancies with known outcomes within study timeline. Adequate monitor data for analysis were available for 150 conceptive cycles. Overall spontaneous first‐trimester pregnancy loss rate was 30% with clinically recognised miscarriage rate of 17%. The difference to LH‐hCG interval median had wider spread for biochemical losses (0.5‐8.5 days) compared with clinical miscarriage (0‐5 days) and viable pregnancies (0‐6 days). Fixed effect hCG profile change distinguished between pregnancy outcomes from as early as day‐2 post‐hCG rise from baseline. CONCLUSIONS: The risk of first‐trimester spontaneous pregnancy loss in our prospective cohort is comparable to studies utilising daily urinary hCG collection and laboratory assays. A wider LH‐hCG interval range is associated with biochemical pregnancy loss and may relate to late or early implantation. Although early hCG changes discriminate between pregnancies that will miscarry from viable pregnancies, this point‐of‐care testing model is not sufficiently developed to be predictive. |
format | Online Article Text |
id | pubmed-7496486 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74964862020-09-25 Peri‐implantation urinary hormone monitoring distinguishes between types of first‐trimester spontaneous pregnancy loss Foo, Lin Johnson, Sarah Marriott, Lorrae Bourne, Tom Bennett, Phillip Lees, Christoph Paediatr Perinat Epidemiol Special Issue: Leveraging Technology BACKGROUND: Lutenising hormone (LH) and human chorionic gonadotropin (hCG) hormone are useful biochemical markers to indicate ovulation and embryonic implantation, respectively. We explored “point‐of‐care” LH and hCG testing using a digital home‐testing device in a cohort trying to conceive. OBJECTIVE: To determine conception and spontaneous pregnancy loss rates, and to assess whether trends in LH‐hCG interval which are known to be associated with pregnancy viability could be identified with point‐of‐care testing. METHODS: We recruited healthy women aged 18‐44 planning a pregnancy. Participants used a home monitor to track LH and hCG levels for 12 menstrual cycles or until pregnancy was conceived. Pregnancy outcomes (viable, clinical miscarriage, or biochemical pregnancy loss) were recorded. Monitor data were analysed by a statistician blinded to pregnancy outcome. RESULTS: From 387 recruits, there were 290 pregnancies with known outcomes within study timeline. Adequate monitor data for analysis were available for 150 conceptive cycles. Overall spontaneous first‐trimester pregnancy loss rate was 30% with clinically recognised miscarriage rate of 17%. The difference to LH‐hCG interval median had wider spread for biochemical losses (0.5‐8.5 days) compared with clinical miscarriage (0‐5 days) and viable pregnancies (0‐6 days). Fixed effect hCG profile change distinguished between pregnancy outcomes from as early as day‐2 post‐hCG rise from baseline. CONCLUSIONS: The risk of first‐trimester spontaneous pregnancy loss in our prospective cohort is comparable to studies utilising daily urinary hCG collection and laboratory assays. A wider LH‐hCG interval range is associated with biochemical pregnancy loss and may relate to late or early implantation. Although early hCG changes discriminate between pregnancies that will miscarry from viable pregnancies, this point‐of‐care testing model is not sufficiently developed to be predictive. John Wiley and Sons Inc. 2020-02-13 2020-09 /pmc/articles/PMC7496486/ /pubmed/32056241 http://dx.doi.org/10.1111/ppe.12613 Text en © 2020 The Authors. Paediatric and Perinatal Epidemiology published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Special Issue: Leveraging Technology Foo, Lin Johnson, Sarah Marriott, Lorrae Bourne, Tom Bennett, Phillip Lees, Christoph Peri‐implantation urinary hormone monitoring distinguishes between types of first‐trimester spontaneous pregnancy loss |
title | Peri‐implantation urinary hormone monitoring distinguishes between types of first‐trimester spontaneous pregnancy loss |
title_full | Peri‐implantation urinary hormone monitoring distinguishes between types of first‐trimester spontaneous pregnancy loss |
title_fullStr | Peri‐implantation urinary hormone monitoring distinguishes between types of first‐trimester spontaneous pregnancy loss |
title_full_unstemmed | Peri‐implantation urinary hormone monitoring distinguishes between types of first‐trimester spontaneous pregnancy loss |
title_short | Peri‐implantation urinary hormone monitoring distinguishes between types of first‐trimester spontaneous pregnancy loss |
title_sort | peri‐implantation urinary hormone monitoring distinguishes between types of first‐trimester spontaneous pregnancy loss |
topic | Special Issue: Leveraging Technology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496486/ https://www.ncbi.nlm.nih.gov/pubmed/32056241 http://dx.doi.org/10.1111/ppe.12613 |
work_keys_str_mv | AT foolin periimplantationurinaryhormonemonitoringdistinguishesbetweentypesoffirsttrimesterspontaneouspregnancyloss AT johnsonsarah periimplantationurinaryhormonemonitoringdistinguishesbetweentypesoffirsttrimesterspontaneouspregnancyloss AT marriottlorrae periimplantationurinaryhormonemonitoringdistinguishesbetweentypesoffirsttrimesterspontaneouspregnancyloss AT bournetom periimplantationurinaryhormonemonitoringdistinguishesbetweentypesoffirsttrimesterspontaneouspregnancyloss AT bennettphillip periimplantationurinaryhormonemonitoringdistinguishesbetweentypesoffirsttrimesterspontaneouspregnancyloss AT leeschristoph periimplantationurinaryhormonemonitoringdistinguishesbetweentypesoffirsttrimesterspontaneouspregnancyloss |